Successful Treatment of a Patient with anti-PD1 Antibody-Resistant Advanced Mucosal Melanoma with Nivolumab, Ipilimumab plus Denosumab Combination Therapy

Since the incidence of mucosal melanoma is higher in the Japanese population compared to Caucasians, and since mucosal melanoma possesses a lower mutation burden compared to cutaneous melanoma, the efficacy of anti-PD1 antibody (Ab) monotherapy for mucosal melanoma is limited. Therefore, other targe...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Case Rep Oncol
Autori principali: Fujimura, Taku, Kambayashi, Yumi, Ohuchi, Kentaro, Amagai, Ryo, Sato, Yota, Tanita, Kayo, Hashimoto, Akira, Aiba, Setsuya
Natura: Artigo
Lingua:Inglês
Pubblicazione: S. Karger AG 2020
Soggetti:
Case Report
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7154272/
https://ncbi.nlm.nih.gov/pubmed/32308589
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000506327
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi